药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Marimastat
TD-8954
The risk or severity of adverse effects can be increased when Bupropion is combined with TD-8954.
Marimastat
Urapidil
The risk or severity of adverse effects can be increased when Bupropion is combined with Urapidil.
Marimastat
Indiplon
The risk or severity of adverse effects can be increased when Bupropion is combined with Indiplon.
Marimastat
AZD-3043
The risk or severity of adverse effects can be increased when Bupropion is combined with AZD-3043.
Marimastat
Benzodiazepine
The risk or severity of adverse effects can be increased when Bupropion is combined with Benzodiazepine.
Marimastat
Piritramide
The risk or severity of adverse effects can be increased when Bupropion is combined with Piritramide.
Marimastat
Ketanserin
The risk or severity of adverse effects can be increased when Bupropion is combined with Ketanserin.
Marimastat
Orvepitant
The risk or severity of adverse effects can be increased when Bupropion is combined with Orvepitant.
Marimastat
Esreboxetine
The risk or severity of adverse effects can be increased when Bupropion is combined with Esreboxetine.
Marimastat
Piclozotan
The risk or severity of adverse effects can be increased when Bupropion is combined with Piclozotan.
Marimastat
Carisbamate
The risk or severity of adverse effects can be increased when Bupropion is combined with Carisbamate.
Marimastat
Eltanolone
The risk or severity of adverse effects can be increased when Bupropion is combined with Eltanolone.
Marimastat
Cerlapirdine
The risk or severity of adverse effects can be increased when Bupropion is combined with Cerlapirdine.
Marimastat
Eplivanserin
The risk or severity of adverse effects can be increased when Bupropion is combined with Eplivanserin.
Marimastat
Sarpogrelate
The risk or severity of adverse effects can be increased when Bupropion is combined with Sarpogrelate.
Marimastat
Vinpocetine
The risk or severity of adverse effects can be increased when Bupropion is combined with Vinpocetine.
Marimastat
MK-212
The risk or severity of adverse effects can be increased when Bupropion is combined with MK-212.
Marimastat
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Bupropion is combined with m-Chlorophenylpiperazine.
Marimastat
Imagabalin
The risk or severity of adverse effects can be increased when Bupropion is combined with Imagabalin.
Marimastat
Vabicaserin
The risk or severity of adverse effects can be increased when Bupropion is combined with Vabicaserin.